文献速递肾移植慢性肾脏病

亚临床认知障碍与肾移植候选登记的关系

Subclinical Cognitive Impairment and Listing for Kidney Transplantation.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-03-19

这项单中心纵向队列研究纳入349例接受肾移植评估的患者,用蒙特利尔认知评估筛查认知障碍(评分<26)。认知障碍患者登记等待移植的时间更长(中位10.6 vs 6.3个月,P=0.01),且认知评分每低1分,登记可能性独立降低(HR 0.93,95%CI 0.88-0.99,P=0.02)。

要点

  • 认知障碍患者肾移植登记等待时间显著延长(中位10.6 vs 6.3个月)。
  • 蒙特利尔认知评估评分每低1分,登记可能性独立降低7%(HR 0.93)。
  • 1个月、6个月、1年登记比例认知障碍组均显著低于无认知障碍组。

核心结论

  • 认知障碍与肾移植登记可能性降低独立相关,并与登记等待时间延长相关。

研究设计与样本

  • 单中心纵向队列研究,纳入349例初次接受肾移植评估并完成蒙特利尔认知评估的患者。
  • 认知障碍定义为蒙特利尔认知评估评分<26,移植选择委员会对评分不知情。
  • 采用Kaplan-Meier分析和Cox比例风险模型(校正年龄、性别、种族/民族、吸烟、冠心病、糖尿病)评估认知评分与登记的关系。

主要发现

  • 认知障碍患者登记等待时间中位10.6个月,无认知障碍患者为6.3个月(log rank检验P=0.01)。
  • 蒙特利尔认知评估评分每低1分,登记可能性独立降低(HR 0.93,95%CI 0.88-0.99,P=0.02)。
  • 认知障碍组与无认知障碍组登记比例:1个月2% vs 11%,6个月17% vs 37%,1年23% vs 41%(所有P<0.001)。

关键数值与推荐

  • 认知障碍判定标准:蒙特利尔认知评估评分<26。
  • 认知障碍患者登记等待时间中位10.6个月,无认知障碍患者6.3个月(P=0.01)。
  • 认知评分每低1分,登记风险比HR 0.93(95%CI 0.88-0.99,P=0.02)。
  • 登记比例差异:1个月2% vs 11%,6个月17% vs 37%,1年23% vs 41%(P<0.001)。

临床怎么用

  • 肾移植评估中应关注认知功能,认知障碍可能影响登记进程,需针对性支持以促进公平登记。

局限性

  • 单中心研究,结果外推需谨慎。
  • 认知障碍定义仅基于蒙特利尔认知评估评分<26,未使用全面神经心理学评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Cognitive impairment is common in patients with kidney disease and can affect physicians' perception and/or patients' ability to complete the pretransplant evaluation. We examined whether cognitive impairment influences the likelihood for transplant listing and whether patients with cognitive impairment take longer to be listed. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a single-center longitudinal cohort study. Patients presenting for their index kidney transplant evaluation were screened for cognitive impairment using the Montreal Cognitive Assessment. A score <26 indicated cognitive impairment. The transplant selection committee was blinded to the scores. Kaplan-Meier analysis assessed time to active listing by level of cognition. A Cox proportional hazards model that included age, sex, race/ethnicity, smoking, coronary artery disease, and diabetes was constructed to evaluate the association between Montreal Cognitive Assessment score and listing for transplant. RESULTS: In total, 349 patients who underwent Montreal Cognitive Assessment testing at their initial visit were included in the analysis. Patients with cognitive impairment were more likely to be older, black, and smokers. The time to listing in patients with cognitive impairment was longer than the time to listing in those with no cognitive impairment (median time, 10.6 versus 6.3 months; log rank test P=0.01). Cognitive impairment was independently associated with a lower likelihood of being listed for transplant (hazard ratio, 0.93 per unit lower Montreal Cognitive Assessment score; 95% confidence interval, 0.88 to 0.99; P=0.02). A lower proportion of patients with cognitive impairment were listed compared with patients without cognitive impairment at 1 month (2% versus 11%), 6 months (17% versus 37%), and 1 year (23% versus 41%), (P<0.001 for all). CONCLUSIONS: Cognitive impairment is associated with a lower likelihood of being listed for kidney transplant, and is associated with longer time to transplant listing.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Gupta A, Montgomery RN, Bedros V, et al. Subclinical Cognitive Impairment and Listing for Kidney Transplantation. Clin J Am Soc Nephrol. 2019. PMID: 30890576. doi:10.2215/CJN.11010918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。